We have changed our name from Cure Our Ovarian Cancer to the Ovarian Cancer Foundation NZ » Read More

Formerly Cure Our Ovarian Cancer > Read more

Support low-grade serous ovarian cancer in Canada

The Low-Grade Serous Ovarian Cancer Initiative has proudly partnered with the BC Cancer Foundation since 2018 to fund research specifically targeting low-grade serous ovarian cancer (LGSOC) in Canada. The BC Cancer Foundation, as the fundraising partner of BC Cancer, supports world-leading scientists and clinicians across British Columbia.

Through our joint efforts in fundraising and donations, we can significantly advance knowledge and progress treatments for LGSOC. Since the BC Cancer Foundation’s broader focus covers all cancers, we encourage you to direct your donations or fundraising through the links on this page to ensure that your support benefits the LGSOC-specific research fund.

Dr Mark Carey and his research

The BC Cancer Foundation supports Dr. Mark Carey, a leading gynaecological oncologist and LGSOC researcher in Canada.

Since starting his work on LGSOC in 2013, Dr. Carey has established one of the world’s largest LGSOC research laboratories in Vancouver. His lab is renowned for its expertise in producing LGSOC cell lines – living scientific models essential for advancing research. The lab addresses LGSOC from multiple angles to improve survival rates and develop new treatments.

Fundraise or donate today to help us fund transformational LGSOC research!

LGSOC hero: Amy MacRae

Amy MacRae was diagnosed with low-grade serous ovarian cancer in 2017 at just 32 years old. Despite undergoing various targeted therapies, chemotherapy, and multiple challenging surgeries, Amy’s focus remained on maximising her time with her husband, Garreth, her daughter, Evie, and her family and friends.

In 2019, Amy visited BC Cancer’s LGSOC laboratory to learn more about their efforts to improve survival rates for women with this disease. Determined to support this crucial research, Amy sought to make a difference for future patients.

Amy passed away peacefully on June 1, 2020. To honour her memory, her family established a fundraising page – Amy’s Living Legacy – to support ongoing LGSOC research with the hope of finding a cure. 

The Amy Award was established to help contribute to Amy’s Living Legacy. Amy was a talented writer, and the award goes to an exception work of memoir writing. Along with raising funds, the annual competition is also a powerful way to raise awareness of LGSOC.

To date, Amy’s Living Legacy has raised over $136,000 CAD for LGSOC research.

This cancer has taken from me more than I ever could have imagined. But it has also made me more grateful than I ever have been for the simple things.

Outcomes for this disastrous disease haven’t improved in over 50 years. We need to demand new research and more funding, on par with the resources available to help my sisters with breast cancer. I am grateful for every day I have here and I encourage you to help me change the outcomes for future women with this disease.

Hug someone you love really tight, eat your favourite food just because you can, sprint down your street and yell at the top of your lungs. We take so much of this beautiful life for granted.

Amy